Physician
Contra Costa Pathology Associates
Contra Costa Pathology Associates was paid $1.68M by Medicaid between Jan 2018 and Nov 2024, across 120 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 35% of everything it billed.
33Billing provider infoCONTRA COSTA PATHOLOGY ASSOCIATES
CONCORD, CA 94520
CONCORD, CA 94520
33aNPI1417361411assigned 06/17/2014
33bProvider typeCytopathology Physician
28Total paid$1.68M
24GClaims554,828
24DCodes billed120
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Cytopathology Physician providers in California
Rank by total paid#8 of 69
Median peer was paid$50K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,102 | $85K | |
| 2019 | 85,229 | $180K | |
| 2020 | 87,014 | $264K | |
| 2021 | 64,945 | $239K | |
| 2022 | 90,521 | $347K | |
| 2023 | 81,341 | $289K | |
| 2024incomplete | 101,676 | $275K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 35% | 12,168 | 11,351 | $596K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.9% | 85,029 | 45,798 | $115K |
| 80053 | Comprehensive metabolic panel | 5.9% | 53,291 | 38,576 | $100K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4.4% | 1,471 | 1,402 | $73K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.8% | 41,175 | 15,910 | $63K |
| 82947 | 3.5% | 22,990 | 7,031 | $59K | |
| 84484 | 2.5% | 19,881 | 15,715 | $41K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.3% | 2,518 | 2,245 | $38K |
| 83880 | 2.0% | 5,618 | 4,331 | $34K | |
| 83735 | 1.8% | 23,267 | 9,936 | $31K | |
| 87040 | 1.6% | 8,284 | 6,344 | $27K | |
| 84145 | 1.6% | 5,966 | 3,490 | $26K |
108 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.5% | 3,980 | $26K |
| 83605 | 1.4% | 9,444 | $24K | |
| 83690 | 1.4% | 18,951 | $23K | |
| 86923 | 1.3% | 2,081 | $23K | |
| 82803 | 1.3% | 5,478 | $21K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.1% | 603 | $18K |
| 84703 | 1.0% | 13,510 | $18K | |
| 81001 | <1% | 27,670 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,371 | $16K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 197 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,817 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,185 | $14K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,182 | $14K |
| 87077 | <1% | 5,940 | $12K | |
| 84702 | <1% | 4,307 | $11K | |
| 84100 | <1% | 11,651 | $11K | |
| 85730 | <1% | 8,195 | $11K | |
| 87186 | <1% | 5,356 | $10K | |
| 85027 | <1% | 7,237 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,845 | $8K |
| 85610 | <1% | 10,800 | $8K | |
| 87070 | <1% | 4,509 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 669 | $7K |
| 80202 | <1% | 2,674 | $6K | |
| 84132 | <1% | 6,454 | $6K | |
| 82728 | <1% | 2,648 | $6K | |
| 87641 | <1% | 902 | $6K | |
| 82330 | <1% | 1,155 | $5K | |
| 82550 | <1% | 3,718 | $5K | |
| 85379 | <1% | 2,816 | $5K | |
| 86140 | <1% | 5,527 | $5K | |
| 86920 | <1% | 454 | $5K | |
| 85014 | <1% | 7,795 | $4K | |
| 85018 | <1% | 7,311 | $4K | |
| 80061 | Lipid panel | <1% | 1,711 | $4K |
| 87081 | <1% | 3,416 | $4K | |
| 80076 | <1% | 2,867 | $4K | |
| 84295 | <1% | 2,713 | $4K | |
| 82607 | <1% | 1,322 | $3K | |
| 82140 | <1% | 1,320 | $3K | |
| 82746 | <1% | 1,266 | $3K | |
| 85049 | <1% | 4,121 | $3K | |
| 87205 | <1% | 3,964 | $3K | |
| 87075 | <1% | 1,433 | $3K | |
| 82010 | <1% | 1,462 | $3K | |
| 83550 | <1% | 1,850 | $3K | |
| 84439 | <1% | 1,592 | $2K | |
| 83540 | <1% | 1,885 | $2K | |
| 86901 | <1% | 4,149 | $2K | |
| 83615 | <1% | 1,779 | $2K | |
| 86900 | <1% | 4,031 | $2K | |
| 84134 | <1% | 764 | $2K | |
| 82553 | <1% | 787 | $2K | |
| 86850 | <1% | 3,199 | $2K | |
| 82565 | <1% | 1,835 | $2K | |
| 87449 | <1% | 794 | $2K | |
| 86403 | <1% | 670 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 250 | $1K |
| 88342 | <1% | 33 | $1K | |
| 80069 | <1% | 805 | $1K | |
| 85652 | <1% | 2,944 | $1K | |
| 87340 | <1% | 732 | $1K | |
| 87581 | <1% | 197 | $1K | |
| 87486 | <1% | 195 | $1K | |
| 85384 | <1% | 458 | $1K | |
| 89050 | <1% | 261 | $820.76 | |
| 82248 | <1% | 867 | $768.00 | |
| 85347 | <1% | 510 | $758.02 | |
| 82570 | <1% | 665 | $699.54 | |
| 84300 | <1% | 707 | $631.73 | |
| 89051 | <1% | 154 | $610.90 | |
| 80047 | <1% | 334 | $550.94 | |
| 86769 | <1% | 12 | $520.00 | |
| 87210 | <1% | 683 | $494.62 | |
| 87324 | <1% | 215 | $366.88 | |
| 82247 | <1% | 357 | $301.62 | |
| 81003 | <1% | 773 | $301.38 | |
| 88304 | <1% | 12 | $283.44 | |
| 82040 | <1% | 345 | $274.40 | |
| 84550 | <1% | 319 | $256.00 | |
| 84478 | <1% | 257 | $239.20 | |
| 81015 | <1% | 441 | $231.87 | |
| 84450 | <1% | 254 | $230.56 | |
| 84075 | <1% | 254 | $217.46 | |
| 87116 | <1% | 89 | $216.58 | |
| 84520 | <1% | 264 | $173.69 | |
| 84155 | <1% | 278 | $168.74 | |
| 87102 | <1% | 88 | $163.74 | |
| 85520 | <1% | 34 | $130.53 | |
| 85048 | <1% | 212 | $96.75 | |
| 82272 | <1% | 71 | $88.32 | |
| 87206 | <1% | 75 | $87.36 | |
| 87045 | <1% | 42 | $64.74 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $56.70 |
| 87420 | <1% | 72 | $55.42 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $49.68 |
| 87427 | <1% | 13 | $38.72 | |
| 83930 | <1% | 32 | $36.42 | |
| 80164 | <1% | 12 | $31.33 | |
| 83935 | <1% | 26 | $29.77 | |
| 80329 | <1% | 1,876 | $27.00 | |
| 86706 | <1% | 13 | $24.70 | |
| 87046 | <1% | 42 | $20.28 | |
| 82945 | <1% | 27 | $19.14 | |
| 84157 | <1% | 29 | $18.00 | |
| 85045 | <1% | 12 | $7.92 | |
| 80320 | 0% | 376 | $0.00 | |
| 87507 | 0% | 65 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLATNER, BARRY (MANAGING PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Contra Costa Pathology Associates | Pleasant Hill, CA | $1.59M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.